Coverage
-
September 06, 2013
Avanir Pharmaceuticals Inc. said Friday it has reached a settlement with Wockhardt Ltd. over its planned generic version of mental health drug Nuedexta, ending a patent infringement dispute in Delaware federal court.
1 other articles on this case.
View all »